Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori

International Journal of Antimicrobial Agents

Volumn 25, Issue 5, 2005, Pages 385-391

  Collado, M C ^a,b   Gonzalez A ^b   Gonzalez R ^c   Hernandez M ^b   Ferrus M A ^b   Sanz, Y ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Antibiotic resistance; Antimicrobial peptides; Bacteriocins; Bifidobacterium; Helicobacter pylori

Indexed keywords

ACETIC ACID; CARBOXYLIC ACID DERIVATIVE; CLARITHROMYCIN; LACTIC ACID; METRONIDAZOLE; PROBIOTIC AGENT; PROTEINASE; TRIACYLGLYCEROL LIPASE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TEMPERATURE SENSITIVITY;

EID: 17644426314     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.01.017     Document Type: Article

References (23)

1. M.F. Go Natural history and epidemiology of Helicobacter pylori infection Aliment Pharm Ther 16 2002 1 15
2. M.J. Blaser, and C. Atherton Helicobacter pylori persistence: biology and disease J Clin Invest 113 2004 321 333
3. D.Y. Graham Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model Gastroenterology 113 1997 1983 1991
4. JM.T. Hamilton-Miller The role of probiotics in the treatment and prevention of Helicobacter pylori infection Int J Antimicrob Agents 22 2003 360 366
5. S. Matsumoto, Y. Washizuka, and Y. Matsumoto Appearance of metronidazole-resistant Helicobacter pylori strain in an Infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains Antimicrob Agents Chemother 41 1997 2602 2605
6. D.Y. Graham Community acquired acute Helicobacter pylori gastritis J Gastroenterol Hepatol 15 2000 1353 1355
7. A.C. Ouwehand, S. Salminen, and E. Isolauri Probiotics: an overview of beneficial effects Antonie van Leeuwenhoek 82 2002 279 289
8. M.F. Bernet, D. Brassart, and J.R. Neeser Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell-attachment and cell-invasion by enterovirulent bacteria Gut 35 1994 483 489
9. D. Sgouras, P. Maragkoudakis, and K. Petraki In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota Appl Environ Microbiol 70 2004 518 526
10. Z. Yildirim, and M.G. Johnson Characterization and antimicrobial spectrum of Bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454 J Food Prot 61 1998 47 51
11. M.J. Gasson Plasmid complements of Streptococcus lactis NCDO712 and other lactic streptococci after protoplast induced curing J Bacteriol 154 1983 1 9
12. Y. Nebra, and A.R. Blanch A new selective medium for Bifidobacterium spp Appl Environ Microbiol 65 1999 5173 5176
13. K. Wilson Preparation of genomic DNA from bacteria F.M. Ausubel R. Brent R.E. Kingston Current protocols in molecular biology 1987 John Wiley & Sons New York
14. C. Burucoa, V. Lhomme, and J.L. Fauchere Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates: experimental results and meta-analysis J Clin Microbiol 37 1999 4071 4080
15. P. Kaufmann, A. Pfefferkorn, and M. Teuber Identification and quantification of Bifidobacterium species isolated from food with genus-specific 16S rRNA-targeted probes by colony hybridisation and PCR Appl Environ Microbiol 63 1997 1268 1273
16. S. Tynkkynen, R. Satokari, and M. Sarela Comparison of ribotyping, randomly amplified polymorphic DNA analysis, and pulsed-field gel electrophoresis in typing of Lactobacillus rhamnosus and Lactobacillus casei strains Appl Environ Microbiol 65 1999 3908 3914
17. F. Megraud, N. Lehn, and T. Lind Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study Antimicrob Agents Chemother 43 1999 2747 2752
18. C. Felley, and P. Michetti Probiotics and Helicobacter pylori Best Pract Res Clin Gastroenterol 17 2003 785 791
19. Y. Aiba, N. Suzuki, and A.M. Kabir Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model Am J Gastroenterol 93 1998 2097 2101
20. I. Sakamoto, M. Igarashi, and K. Kimura Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans J Antimicrob Chemother 47 2001 709 710
21. T.S. Kim, J.W. Hur, and M.A. Yu Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria J Food Prot 66 2003 3 12
22. W.P. Charteriss, P.M. Kelly, and L. Morelli Effect of conjugated bile salts on antibiotic susceptibility of bile salt-tolerant Lactobacillus and Bifidobacterium isolates J Food Prot 63 2000 1369 1376
23. T. Falsafis, F. Mobasheri, and F. Nariman Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran J Clin Microbiol 42 2004 387 389